Next Article in Journal
Stopping the SARS-CoV-2 Surge in the USA-CDC Recommendations and Ground Realities
Previous Article in Journal
Coronavirus—Preventing an Occupational Hazard among Doctors
 
 
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Letter

Amiodarone and Diffuse Alveolar Hemorrhage

by
Ilias C. Papanikolaou
*,
Ioanna Makou
and
Eleftherios Markatis
General Hospital of Corfu, Department of Pulmonary Medicine, Corfu, Greece
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2020, 88(2), 169-171; https://doi.org/10.5603/ARM.2020.0095
Submission received: 27 January 2020 / Revised: 21 February 2020 / Accepted: 21 February 2020 / Published: 30 April 2020

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Amiodarone, a common anti-arrhythmic drug, is well known for its pulmonary toxicity [...]

Share and Cite

MDPI and ACS Style

Papanikolaou, I.C.; Makou, I.; Markatis, E. Amiodarone and Diffuse Alveolar Hemorrhage. Adv. Respir. Med. 2020, 88, 169-171. https://doi.org/10.5603/ARM.2020.0095

AMA Style

Papanikolaou IC, Makou I, Markatis E. Amiodarone and Diffuse Alveolar Hemorrhage. Advances in Respiratory Medicine. 2020; 88(2):169-171. https://doi.org/10.5603/ARM.2020.0095

Chicago/Turabian Style

Papanikolaou, Ilias C., Ioanna Makou, and Eleftherios Markatis. 2020. "Amiodarone and Diffuse Alveolar Hemorrhage" Advances in Respiratory Medicine 88, no. 2: 169-171. https://doi.org/10.5603/ARM.2020.0095

Article Metrics

Back to TopTop